Ebola: an experimental treatment being tested
WHO has agreed to the use of experimental serum ZMapp in two Liberian doctors infected with Ebola virus. This experimental treatment, developed by a private laboratory was successfully administered two state-uniens patients. Research in this area is ongoing.
This electron microscopy image shows Ebola virions. © Public Library of Science, PLoS Biology 2005
With already more than 1,000 people dead, the West Africa is currently experiencing the largest outbreak of virus Ebola in its history. Affected Guinea, Liberia and Sierra Leone. These exceptional circumstances have led the WHO to endorse the use of serums which experimental neither efficiency nor the side effects are not known ... Two Liberian doctors infected with viruses should benefit from this treatment.
The Ebola virus causes hemorrhagic fever , a particularly virulent disease that leads to death in 25-90% of cases. The virus is spread through contact with blood and body fluids of persons or infected animals. http://enjoycoloring.com/animation/ The first outbreaks were described in 1976 is no treatment or vaccine approved to treat or prevent disease. Ideally, doctors would like to have a treatment relieving symptoms and can be used as prevention for health personnel who work in areas where the virus is prevalent.
In 1976, there were 318 cases of hemorrhagic fever caused by the Ebola virus in Zaire